Unmonitored use of herbal medicine by patients with breast cancer: reframing expectations

Journal of Cancer Research and Clinical Oncology

Volumn 143, Issue 11, 2017, Pages 2267-2273

  Samuels, Noah ^a   Ben Arye, Eran ^b,c   Maimon, Yair ^a   Berger, Raanan ^a  

^a SHEBA MEDICAL CENTER   (Israel)

^b CLALIT HEALTH SERVICES   (Israel)

^c TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Breast cancer; Complementary integrative medicine; Herbal medicine; Herb drug interaction; Safety

Indexed keywords

ANTINEOPLASTIC AGENT; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; HERBACEOUS AGENT;

ADOPTION; ADULT; ALTERNATIVE MEDICINE; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CONSULTATION; CONTROLLED STUDY; DIETARY SUPPLEMENT; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; HERBAL MEDICINE; HUMAN; MAJOR CLINICAL STUDY; MEDICATION COMPLIANCE; MIDDLE AGED; PATIENT COMPLIANCE; PHYSICIAN; PRIORITY JOURNAL; RETROSPECTIVE STUDY; UNSPECIFIED SIDE EFFECT; BREAST NEOPLASMS; FOLLOW UP; METASTASIS; PHYTOTHERAPY; PROCEDURES; PROGNOSIS; QUALITY OF LIFE; TUMOR INVASION; UTILIZATION;

BREAST NEOPLASMS; COMPLEMENTARY THERAPIES; FEMALE; FOLLOW-UP STUDIES; HERBAL MEDICINE; HUMANS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; PATIENT COMPLIANCE; PHYSICIANS; PHYTOTHERAPY; PROGNOSIS; QUALITY OF LIFE; RETROSPECTIVE STUDIES;

EID: 85021725691     PISSN: 01715216     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/s00432-017-2471-x     Document Type: Article

References (24)

1. Barbuti AM, Chen ZS (2015) Paclitaxel through the ages of anticancer therapy: exploring its role in chemoresistance and radiation therapy. Cancers Basel 7(4):2360–2371
2. Barton DL, Liu H, Dakhil SR, Linquist B, Sloan JA, Nichols CR, McGinn TW, Stella PJ, Seeger GR, Sood A, Loprinzi CL (2013) Wisconsin Ginseng (Panax quinquefolius) to improve cancer-related fatigue: a randomized, double-blind trial, N07C2. J Natl Cancer Inst 105(16):1230–1238
3. Ben-Arye E, Schiff E, Zollman C, Heusser P, Mountford P, Frenkel M, Bar-Sela G, Lavie O (2013) Integrating complementary medicine in supportive cancer care models across four continents. Med Oncol 30(2):511
4. Ben-Arye E, Kruger D, Samuels N, Keinan-Boker L, Shalom T, Schiff E (2014) Assessing patient adherence to a complementary medicine treatment regimen in an integrative supportive care setting. Support Care Cancer 22(3):627–644
5. Ben-Arye E, Samuels N, Goldstein LH, Mutafoglu K, Omran S, Schiff E, Charalambous H, Dweikat T, Ghrayeb I, Bar-Sela G, Turker I, Hassan A, Hassan E, Saad B, Nimri O, Kebudi R, Silbermann M (2016) Potential risks associated with traditional herbal medicine use in cancer care: a study of Middle Eastern oncology health care professionals. Cancer 122(4):598–610
6. Boon HS, Olatunde F, Zick SM (2007) Trends in complementary/alternative medicine use by breast cancer survivors: comparing survey data from 1998 and 2005. BMC Womens Health 7:4
7. Corina G, Christine H, Klein G (2016) Oncologists’ experiences of discussing complementary and alternative treatment options with their cancer patients. A qualitative analysis. Support Care Cancer 24(9):3857–3862
8. Cragg GM, Newman DJ (2005) Plants as a source of anti-cancer agents. J Ethnopharmacol 100:72–79
9. Deng G (2008) Integrative cancer care in a US academic cancer centre: the Memorial Sloan–Kettering experience. Curr Oncol 15(Suppl 2):s108.es68–s108.es71
10. Eisenberg DM, Kessler RC, Foster C, Norlock FE, Calkins DR, Delblanco TL (1993) Unconventional medicine in the United States. Prevalence, costs, and patterns of use. N Engl J Med 328:246–252
11. Frenkel M, Cohen L, Peterson N, Palmer JL, Swint K, Bruera E (2010) Integrative medicine consultation service in a comprehensive cancer center: findings and outcomes. Integr Cancer Ther 9(3):276–283
12. Haefeli WE, Carls A (2014) Drug interactions with phytotherapeutics in oncology. Expert Opin Drug Metab Toxicol 10(3):359–377
13. Heller AR, Fischer S, Rossel T, Geiger S, Siegert G, Ragaller M, Zimmerman T, Koch T (2002) Impact of n-3 fatty acid supplemented parenteral nutrition on haemostasis patterns after major abdominal surgery. Br J Nutr 87(Suppl 1):S95–S101
14. Hershman DL, Unger JM, Crew KD, Minasian LM, Awad D, Moinpour CM, Hansen L, Lew DL, Greenlee H, Fehrenbacher L, Wade JL 3rd, Wong SF, Hortobagyi GN, Meyskens FL, Albain KS (2013) Randomized double-blind placebo-controlled trial of acetyl-l-carnitine for the prevention of taxane-induced neuropathy in women undergoing adjuvant breast cancer therapy. J Clin Oncol 31(20):2627–2633
15. Huebner J, Marienfeld S, Abbenhardt C, Ulrich C, Muenstedt K, Micke O, Muecke R, Loeser C (2014) Counseling patients on cancer diets: a review of the literature and recommendations for clinical practice. Anticancer Res 34(1):39–48
16. Konmun J, Danwilai K, Ngamphaiboon N, Sripanidkulchai B, Sookprasert A, Subongkot S (2017) A phase II randomized double-blind placebo-controlled study of 6-gingerol as an anti-emetic in solid tumor patients receiving moderately to highly emetogenic chemotherapy. Med Oncol 34(4):69
17. Kulp KS, Montgomery JL, Nelson DO, Cutter B, Latham ER, Shattuck DL, Klotz DM, Bennett LM (2006) Essiac and Flor-Essence herbal tonics stimulate the in vitro growth of human breast cancer cells. Breast Cancer Res Treat 98:249–259
18. Lewith G, Aldridge E (eds) (1991) Complementary medicine and the European community. C.W. Daniel, Saffron Walden
19. Matthews AK, Sellergren SA, Huo D, List M, Fleming G (2007) Complementary and alternative medicine use among breast cancer survivors. J Altern Complement Med 13:555–562
20. Prakash P, Misra A, Surin WR, Jain M, Bhatta RS, Pal R, Raj K, Barthwal MK, Dikshit M (2011) Anti-platelet effects of Curcuma oil in experimental models of myocardial ischemia-reperfusion and thrombosis. Thromb Res 127(2):111–118
21. Roberts CS, Baker F, Hann D, Runfola J, Witt C, McDonald J, Livingston ML, Ruiterman J, Ampela R, Kaw OC, Blanchard C (2005) Patient–physician communication regarding use of complementary therapies during cancer treatment. J Psychosoc Oncol 23:35–60
22. Saibul N, Shariff ZM, Rahmat A, Sulaiman S, Yaw YH (2012) Use of complementary and alternative medicine among breast cancer survivors. Asian Pac J Cancer Prev 13:4081–4086
23. Shalom-Sharabi I, Samuels N, Lev E, Lavie O, Keinan-Boker L, Schiff E, Ben-Arye E (2017) Impact of a complementary/integrative medicine program on the need for supportive cancer care-related medications. Support Care Cancer. doi:10.1007/s00520-017-3726-4
24. Shin SC, Choi JS (2009) Effects of epigallocatechin gallate on the oral bioavailability and pharmacokinetics of tamoxifen and its main metabolite, 4-hydroxytamoxifen, in rats. Anticancer Drugs 20(7):584–588